Search research articles
Contact Us
Filters
Showing results (101-110 of 662) with videos related to
Page
of 67
Sort By:
The Hematology Journal : the Official Journal of the European Haematology Association
|
May 29, 2002
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells
Peter Valent, Puchit Samorapoompichit, Wolfgang R Sperr, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 7, 2023
Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment
George N Konstantinou, Marc A Riedl, Peter Valent, et al.
Oncotarget
|
June 15, 2018
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
Karin Bauer, Daniela Berger, Christoph C Zielinski, et al.
Vaccine
|
January 11, 2011
Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
Susanne Vrtala, Monika Fohr, Raffaela Campana, et al.
Blood Advances
|
January 24, 2025
Systemic mastocytosis: current status and challenges in 2024
Celalettin Ustun, Fatma Keklik Karadag, Michael A Linden, et al.
Plos One
|
August 8, 2013
E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model
Daniel Wicklein, Anna Schmidt, Vera Labitzky, et al.
Nature Reviews. Disease Primers
|
April 24, 2025
Mastocytosis
Cem Akin, Michel Arock, Melody C Carter, et al.
Blood
|
October 24, 2002
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
Matthias Mayerhofer, Peter Valent, Wolfgang R Sperr, et al.
Leukemia & Lymphoma
|
December 16, 2014
Dasatinib-induced immunosuppression and recurrent respiratory tract infections
Faruk Obut, Nicole Randall, Jo-Anne H Young, et al.
International Archives of Allergy and Immunology
|
March 29, 2002
Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression
Peter Valent, Cem Akin, Wolfgang R Sperr, et al.
Page
of 67
Search research articles
Search
Showing results (101-110 of 662) with videos related to
Sort By:
Page
of 67
The Hematology Journal : the Official Journal of the European Haematology Association
|
May 29, 2002
Myelomastocytic leukemia: myeloid neoplasm characterized by partial differentiation of mast cell-lineage cells
Peter Valent, Puchit Samorapoompichit, Wolfgang R Sperr, et al.
The Journal of Allergy and Clinical Immunology. in Practice
|
January 7, 2023
Urticaria and Angioedema: Understanding Complex Pathomechanisms to Facilitate Patient Communication, Disease Management, and Future Treatment
George N Konstantinou, Marc A Riedl, Peter Valent, et al.
Oncotarget
|
June 15, 2018
Hitting two oncogenic machineries in cancer cells: cooperative effects of the multi-kinase inhibitor ponatinib and the BET bromodomain blockers JQ1 or dBET1 on human carcinoma cells
Karin Bauer, Daniela Berger, Christoph C Zielinski, et al.
Vaccine
|
January 11, 2011
Genetic engineering of trimers of hypoallergenic fragments of the major birch pollen allergen, Bet v 1, for allergy vaccination
Susanne Vrtala, Monika Fohr, Raffaela Campana, et al.
Blood Advances
|
January 24, 2025
Systemic mastocytosis: current status and challenges in 2024
Celalettin Ustun, Fatma Keklik Karadag, Michael A Linden, et al.
Plos One
|
August 8, 2013
E- and p-selectins are essential for repopulation of chronic myelogenous and chronic eosinophilic leukemias in a scid mouse xenograft model
Daniel Wicklein, Anna Schmidt, Vera Labitzky, et al.
Nature Reviews. Disease Primers
|
April 24, 2025
Mastocytosis
Cem Akin, Michel Arock, Melody C Carter, et al.
Blood
|
October 24, 2002
BCR/ABL induces expression of vascular endothelial growth factor and its transcriptional activator, hypoxia inducible factor-1alpha, through a pathway involving phosphoinositide 3-kinase and the mammalian target of rapamycin
Matthias Mayerhofer, Peter Valent, Wolfgang R Sperr, et al.
Leukemia & Lymphoma
|
December 16, 2014
Dasatinib-induced immunosuppression and recurrent respiratory tract infections
Faruk Obut, Nicole Randall, Jo-Anne H Young, et al.
International Archives of Allergy and Immunology
|
March 29, 2002
Smouldering mastocytosis: a novel subtype of systemic mastocytosis with slow progression
Peter Valent, Cem Akin, Wolfgang R Sperr, et al.
Page
of 67